Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

Suzanne E. Biehn, Dominic T. Moore, Peter M. Voorhees, Reynaldo A. Garcia, Mary Jo Lehman, Claire E. Dees, Robert Z. Orlowski

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint Dive into the research topics of 'Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin'. Together they form a unique fingerprint.

Medicine & Life Sciences